| Predicate |
Object |
| assignee |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentassignee/MD5_1387362b4b7cb2d60e4b3ac0126a893e |
| classificationCPCAdditional |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N2800-245 |
| classificationCPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-6854
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-02
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P37-06
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P43-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-179
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61K38-18
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/A61P17-00
http://rdf.ncbi.nlm.nih.gov/pubchem/patentcpc/G01N33-564 |
| classificationIPCInventive |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/G01N33-564
http://rdf.ncbi.nlm.nih.gov/pubchem/patentipc/A61K38-18 |
| filingDate |
2006-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| inventor |
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_2c70e681d628c3d072d0d63ca62952a8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_06adda5807635bc6e2e1d424709afd76
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_40be52ce256ffda32906d8c520d42f6f
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_5ee09a597cfc0bb8a41a3b9f2690508d
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_68af9f3603188b7789963086bd0693c8
http://rdf.ncbi.nlm.nih.gov/pubchem/patentinventor/MD5_bdb1b24e28b7b79f8201c64d6eb1a601 |
| publicationDate |
2009-08-26-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| publicationNumber |
CN-101517414-A |
| titleOfInvention |
Stimulatory auto-antibodies to the PDGF receptor as pathology marker and therapeutic target |
| abstract |
The invention provides an in vitro method for detecting the presence in a body sample of auto-antibodies for the PDGF receptor suitable for the diagnosis and prognosis of autoimmune diseases, in particular the systemic sclero-is and related diagnostic kits. Use of an inhibitor of ROS and/or Ras-ERK1/2 for the preparation of a medicament for therapeutic treatment of autoimmune diseases or of treating the Graft-Versus-Host- Reaction (GVHR). Pharmaceutical composition comprising an effective amount of an inhibitor of ROS and/or Ras-ERK1/2, and proper diluents, and /or excipients, and/or adjuvants. |
| isCitedBy |
http://rdf.ncbi.nlm.nih.gov/pubchem/patent/CN-105026426-A |
| priorityDate |
2005-07-28-04:00^^<http://www.w3.org/2001/XMLSchema#date> |
| type |
http://data.epo.org/linked-data/def/patent/Publication |